Join to view full profile
601 Elmwood AveRochester, NY 14642
Phone+1 585-275-5006
Fax+1 585-273-1255
Dr. Marshall is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1991 - 1994
UMass Chan - BaystateInternship, Internal Medicine, 1989 - 1990
Harvard Medical SchoolClass of 1989
Certifications & Licensure
NY State Medical License 1994 - 2027
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
Publications & Presentations
PubMed
- 25 citationsSafety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial.Michael J Brownstein, Neal G. Simon, Jeffrey D. Long, Jon W. Yankey, Hilda T Maibach
Journal of Clinical Medicine. 2020-11-16 - 14 citationsThe CLN3 Disease Staging System: A New Tool for Clinical Research in Batten DiseaseMargaux C. Masten, Justin D. Williams, Jennifer Vermilion, Heather R. Adams, Amy Vierhile
Neurology. 2020-06-09 - 3 citationsA novel, hybrid, single- and multi-site clinical trial design for CLN3 disease, an ultra-rare lysosomal storage disorder:Heather R. Adams, Sara Defendorf, Amy Vierhile, Jonathan W. Mink, Frederick J. Marshall
Clinical Trials. 2019-06-11
Press Mentions
URMC to Lead First Gene Therapy Study for Batten DiseaseNovember 3rd, 2021
New Grants Will Accelerate Clinical Trials in Rare Neurological DisordersJune 26th, 2019
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
